AI could help pick the right chemo for pancreatic cancer patients
NCT ID NCT06320717
First seen May 06, 2026 · Last updated May 20, 2026 · Updated 4 times
Summary
This study collects blood and tumor tissue from 100 people with pancreatic cancer who are about to receive standard chemotherapy. Researchers will use artificial intelligence to look for biomarkers that might predict which treatment works best for each person. The goal is to make it easier for doctors to choose the right chemotherapy for future patients based on their unique biology.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Good Samaritan University Hospital
RECRUITINGWest Islip, New York, 11795, United States
Contact Phone: •••-•••-••••
Contact
-
Roswell Park Comprehensive Cancer Center
RECRUITINGBuffalo, New York, 14263, United States
Conditions
Explore the condition pages connected to this study.